Paulo Macro — The $800B Supply Wall Meets Vanishing Liquidity (Jun 2026)

One-line take: Equity funding costs are tightening just as leverage demand (buyside + levered retail products) collides with $200B of IPO supply from SpaceX (SPCX), Anthropic, and OpenAI — really $800B counting the later unlocks. Gross leverage is a function of funding cost and volatility (the first begets the second), top-of-book S&P-futures liquidity is down to $3.5M, and levered-ETF negative gamma has doubled to ~-$20B per 1% S&P move — the derivatives "tail" will wag the cash-equity "dog" until the position is rinsed. He wonders if the SPCX IPO closes the ECM window all by itself, stranding Anthropic/OpenAI — especially with OpenAI mulling a price war (WSJ). The whole AI complex's "cashflow" is the Great Circularity: VC cash relaundered through capital raises, fine until VC flips from buyer to exiter.

1. Stocks & names mentioned

All three names are private (SpaceX lists as SPCX on June 12), so no research links. The "Source" links open the Substack chat note (a written post — no timestamps). The unnamed "picks-and-shovels hardware players" are deliberately not mapped to tickers.

2. Talking points

Ticker	Name	Research	View	What's said	Source
SPCX	SpaceX (IPOs Jun 12 as SPCX)	QT · SA · STK · FA	Negative	The first slug of the $200B supply wall (really $800B with the year-end unlocks) hitting a market with tightening funding costs — "I can't help but wonder if SPCX will close the ECM window for good all by itself."	note ↗
Anthropic	Anthropic (private)	—	Negative	Part of the planned supply wall but may never get its chance if SPCX shuts the ECM window; lumped into the Great Circularity — the AI complex's "cashflow" is VC-sourced cash relaundered via capital raises.	note ↗
OpenAI	OpenAI (private)	—	Negative	Considering "drastic price cuts" anticipating a war for users with Anthropic (per the WSJ) — which threatens its own IPO chance; the flagship of the circular flywheel that "works splendidly until VC flips from buyer to exiter and someone asks for their money back."	note ↗

Funding costs vs the supply wall

Equity funding costs continue to tighten as demand for leverage (buyside + levered retail products) runs headlong into $200B of supply from SPCX, Anthropic, and OpenAI — "check that, $800bln" once the later-2026 unlocks are counted.

The leverage feedback loop — and a liquidity void

Gross leverage is a function of funding cost and volatility; "the first begets the second, and then the feedback loop starts."
Initial signs of this just as top-of-book liquidity disappears to $3.5M in S&P futures — "hard to de-gross into a liquidity void."

Levered-ETF negative gamma doubles

Per Morgan Stanley's QDS team, negative gamma is now ~-$20B for each 1% S&P move, vs ~-$10B at year end.
Expect the derivatives-topology "tail" to increasingly wag the cash-equity "dog" in the coming weeks until the position is properly rinsed.

Out of the Pre-Opex Misdirection Window

The market has exited the Pre-Opex Misdirection Window ahead of next Thursday's (Jun 18) large options expiry — the "cha-cha-cha" of the past three days should now find a direction that sets the tone into quarter end.

Does SPCX close the ECM window?

In this context he wonders if the SpaceX IPO closes the equity-capital-markets window for good all by itself, so Anthropic/OpenAI never get their chance.
Especially as OpenAI is considering drastic price cuts anticipating a war for users with Anthropic (WSJ).

The Great Circularity

The AIs and their picks-and-shovels brethren were special while every number but profitability grew exponentially — the hardware players' "cashflow" is simply VC-sourced cash funneled through AI LLM players via capital raises, out to the hardware names, then relaundered back to the LLMs in a flywheel.
"It all works splendidly until VC flips from buyer to exiter and someone asks for their money back." Stay frosty.

3. In plain English

A jargon-free summary of the thesis behind each name — what it actually is and why that view. (Plain-language companion to the table above; renders on each ticker's consolidated page.)

SpaceX — SpaceX (SPCX) Negative

SpaceX is Elon Musk's rocket-and-Starlink company, about to list on the stock market under the ticker SPCX. Paulo's worry isn't the company itself — it's the sheer size of the sale. When a giant IPO hits, investors have to come up with that cash, usually by selling other stocks or borrowing ("leverage"). Borrowing costs for equity bets are already rising, and SpaceX is just the first of roughly $200 billion of new stock that wants to come to market this year — closer to $800 billion once you count "unlocks" (the dates when insiders from these IPOs become free to sell their own shares).

His question: does this one deal soak up so much money that the "ECM window" (the equity-capital-markets window — the periods when conditions are good enough for companies to sell new shares) slams shut behind it? If so, SpaceX gets out and everyone queued behind it doesn't.

Anthropic — Anthropic Negative

Anthropic is the AI lab behind Claude, expected to IPO later this year. Paulo sees it stuck in line behind SpaceX: if the SpaceX deal exhausts investors' appetite for new shares, Anthropic may never get its window. He also folds it into what he calls the Great Circularity — the observation that much of the AI industry's apparent "cash flow" is really venture-capital money raised by the AI labs, spent on hardware, and recycled back around, rather than profits earned from outside customers. That looks fine while fresh money keeps arriving; it breaks when the venture investors stop buying and start cashing out.

OpenAI — OpenAI Negative

OpenAI (ChatGPT) is also in the IPO queue, and per the Wall Street Journal it is weighing drastic price cuts to win users before Anthropic does. To Paulo a price war is the tell that the exponential-growth story is over: companies with pricing power don't slash prices. Combine that with the circular money flow — VC cash raised by the AI labs, paid out to the chip-and-hardware suppliers, and relaundered back into the labs — and the whole flywheel "works splendidly until VC flips from buyer to exiter and someone asks for their money back."

Key points extracted from the public Substack chat note (in transcript.txt) for personal study. Not investment advice. © Paulo Macro for source material.